Inhibrx Biosciences, Inc.
INBX · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$35 | -$29 | -$43 | -$48 |
| Dep. & Amort. | $1 | $1 | $1 | $1 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $3 | $3 | $2 | $3 |
| Change in WC | -$3 | -$6 | $3 | $0 |
| Other Non-Cash | $1 | $1 | $1 | $0 |
| Operating Cash Flow | -$34 | -$30 | -$36 | -$44 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$0 | $0 | -$0 | -$0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$0 | $0 | -$0 | -$0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $100 | $0 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | -$0 | $33 |
| Financing Cash Flow | $0 | $0 | $100 | $0 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$33 | -$30 | $64 | -$44 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $187 | $217 | $153 | $196 |
| End Cash | $153 | $187 | $217 | $153 |
| Free Cash Flow | -$34 | -$30 | -$36 | -$44 |